# Katie re-audit of version 3

These six cases are prepared for another clinician review. They are not clinically validated.

| Case | Round 1 concern addressed? | Clean chart? | Answer leakage? | Reference supported? | Multiple reasonable answers represented? | Katie status |
| --- | --- | --- | --- | --- | --- | --- |
| VAL-801 | Partial. A precipitant is visible. Infection was not added. | Yes | No direct leak | Yes for continuation of the recorded medicines | Stopping ibuprofen remains possible and is not forbidden | PASS_WITH_MINOR_CONCERN |
| VAL-802 | Partial. No baseline was invented. The Exclude recommendation is preserved historically. | Yes | No | Ambiguous lisinopril decision is marked | Hold is encoded | PASS |
| VAL-803 | Partial. The cause is now visible. The review after C1 stays incomplete. | Yes. Sodium is labeled synthetic. | No | Stop versus hold is marked | Hold is encoded | PASS_WITH_MINOR_CONCERN |
| VAL-805 | Partial. The weight gap and the oral inpatient dose are visible. Intravenous therapy and an ejection fraction were not invented. | Yes | No | Ambiguous diuretic intensity is marked | Continue once daily, and optional extra therapy, are encoded | PASS |
| VAL-809 | Partial. Source findings are visible. Fever and a dental source were not invented. | Yes | No | Antibiotic evidence is sufficient. Lisinopril is ambiguous and marked | Hold is encoded | PASS |
| VAL-813 | Partial. Chronology is coherent. Mycophenolate was not invented, and the question about it was removed. | Yes | No | Antiviral start is supported. Tacrolimus intensity is marked ambiguous | Temporary reduction is encoded | PASS |

DIRECT_ANSWER_LEAK = 0

HIDDEN_REFERENCE_DEPENDENCY = 0

CLINICALLY_INCONSISTENT = 0

CODEBOOK REFERENCES ABSENT FACT = 0

README/V3 MISMATCH is checked by tests/test_set1_v3.py.

OLD ERROR-INJECTION LANGUAGE = 0 in the six resident charts.
